Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.